Hepatocellular carcinoma

@article{Forner2012HepatocellularC,
  title={Hepatocellular carcinoma},
  author={A. Forner and J. Llovet and J. Bruix},
  journal={The Lancet},
  year={2012},
  volume={379},
  pages={1245-1255}
}
Hepatocellular carcinoma is the sixth most prevalent cancer and the third most frequent cause of cancer-related death. Patients with cirrhosis are at highest risk of developing this malignant disease, and ultrasonography every 6 months is recommended. Surveillance with ultrasonography allows diagnosis at early stages when the tumour might be curable by resection, liver transplantation, or ablation, and 5-year survival higher than 50% can be achieved. Patients with small solitary tumours and… Expand
Localized and systemic approaches to treating hepatocellular carcinoma.
  • J. Knox, S. Cleary, L. Dawson
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2015
Treatment of intermediate-stage hepatocellular carcinoma
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
Management strategies for hepatocellular carcinoma: old certainties and new realities
Management of Hepatocellular Carcinoma: Updated Review
Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma
Hepatocellular carcinoma: Therapeutic strategy in 2017
Screening for hepatocellular carcinoma: patient selection and perspectives
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 63 REFERENCES
Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.
Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis.
Design and endpoints of clinical trials in hepatocellular carcinoma.
...
1
2
3
4
5
...